Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Net Current Assets

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Net Current Assets (Including Current Investments) ₹211 Cr₹168 Cr₹69 Cr₹62 Cr₹28 Cr

What is the latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) is ₹211 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹211 Cr
Mar2024₹168 Cr
Mar2023₹69 Cr
Mar2022₹62 Cr
Mar2017₹28 Cr

How is Net Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?

Years Net Current Assets % Change
Mar2025 ₹211 Cr
25.20
Mar2024 ₹168 Cr
145.53
Mar2023 ₹69 Cr
11.35
Mar2022 ₹62 Cr
122.16
Mar2017 ₹28 Cr -

Compare Net Current Assets of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,200.4 Cr -4.1% -0.8% -24.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-4.1%

-0.8%

-24.5%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses